Stifel Nicolaus initiated coverage on shares of Tempus AI (NASDAQ:TEM – Free Report) in a research report sent to investors on Tuesday morning, Marketbeat reports. The brokerage issued a buy rating and a $45.00 target price on the stock.
Other analysts also recently issued reports about the stock. TD Cowen began coverage on shares of Tempus AI in a research report on Tuesday. They issued a buy rating and a $50.00 target price on the stock. JPMorgan Chase & Co. initiated coverage on shares of Tempus AI in a research report on Tuesday. They set an overweight rating and a $42.00 price objective on the stock. Needham & Company LLC initiated coverage on shares of Tempus AI in a research note on Tuesday. They set a buy rating and a $47.00 price objective for the company. Finally, Loop Capital initiated coverage on shares of Tempus AI in a research note on Tuesday. They set a buy rating and a $48.00 price objective for the company. Nine analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of Buy and a consensus target price of $45.63.
Read Our Latest Analysis on TEM
Tempus AI Stock Up 7.1 %
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
- Five stocks we like better than Tempus AI
- What is the Australian Securities Exchange (ASX)
- Sales Breakout Sends This Semiconductor Stock to Record High
- How to Use the MarketBeat Dividend Calculator
- Surprise Buying Opportunity on This Dividend Aristocrat
- How to Use Stock Screeners to Find Stocks
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.